Evidence map›Paper›PMID 35740041›Full record

ReviewAntioxidants (Basel, Switzerland)2022

The Current Status, Bioactivity, Food, and Pharmaceutical Approaches of

Meghna Shashikant, Aarti Bains, Prince Chawla, Melinda Fogarasi, Szabolcs Fogarasi

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Inhibitory effects ofIranian journal of basic medical sciences · 2023
    Article
  4. Mushrooms as future generation healthy foods.Frontiers in nutrition · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Meghna ShashikantDepartment of Food Technology and Nutrition, Lovely Professional University, Phagwara 144411, Punjab, India.
Aarti BainsDepartment of Biotechnology, CT Institute of Pharmaceutical Sciences, South Campus, Jalandhar 144020, Punjab, India.
Prince ChawlaDepartment of Food Technology and Nutrition, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0002-2383-7925
Melinda FogarasiDepartment of Food Engineering, University of Agricultural Sciences and Veterinary Medicine of Cluj Napoca, Calea Mănăstur 3-5, RO-400372 Cluj-Napoca, Romania.ORCID 0000-0002-9561-1183
Szabolcs FogarasiDepartment of Chemical Engineering, Faculty of Chemistry and Chemical Engineering, Babeş-Bolyai University, 11 Arany Janos Street, RO-400028 Cluj-Napoca, Romania.ORCID 0000-0002-9917-6406
Lovely Professional University · INBabeș-Bolyai University · ROPunjab Institute of Medical Sciences · INUniversity of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past few years, mushrooms have been extensively explored in the field of pharmaceutical and food science, and researchers are heading toward the search for vital components with a higher safety margin and multitarget applications. Moreover, among all age group populations, mushroom consumption has increased immensely owing to their great nutritional aspects, desirable organoleptic properties, and aroma. In addition, mushrooms continue to generate much attention chiefly in their consumption as food, as a cure for different ailments, as well as a vital commodity globally, owing to their dietary, antioxidant, and therapeutic values. Mushrooms are considered one of the important and suitable diets for patients having multiple types of diseases. Additionally, due to potential immunomodulatory effects, quality protein, and low fat, and cholesterol content, mushrooms are used as an important ingredient for food formulation. Therefore, this review article provides detailed information on

Indexed as

antioxidantsbioactivityCalocybe indicamushroomtherapeutic application

Identifiers

PMID35740041
PMCPMC9219886
OpenAlexW4281790082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.